-
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
12 Dec 2025 12:00 GMT
… evaluating Plinabulin plus docetaxel compared to docetaxel alone in second- … -type non-small cell lung cancer (NSCLC). Dublin-3’ … stabilizing agents, such as docetaxel, which contributes to its … and could thereby increase docetaxel tolerability. About DUBLIN-3 …
-
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025
11 Dec 2025 12:00 GMT
… evaluate Plinabulin + docetaxel vs. docetaxel in non-squamous … NSQ) non-small cell lung cancer (NSCLC) who progressed … North America Conference on Lung Cancer (NACLC). More … Plinabulin + docetaxel combination compared to docetaxel.
Meaningful improvement …
-
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
06 Dec 2025 20:30 GMT
… squamous non-small cell lung cancer (sqNSCLC). Gotistobart … America Conference on Lung Cancer, hosted by the … who received chemotherapy (docetaxel) as second or … lung cancer (“NSCLC”) covers all epithelial lung cancers other than small cell lung cancer …
-
<![CDATA[5 Key Oncology FDA Approvals From November]]>
12 Dec 2025 21:11 GMT
… hematologic cancers, non-small cell lung cancer (NSCLC), muscle-invasive bladder cancer … with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as a neoadjuvant … HER2-mutant non-small cell lung cancer. News release. Bayer. May 28 …
-
<![CDATA[One-time TIL therapy shows durable responses in advanced lung cancer]]>
19 Nov 2025 23:34 GMT
… nonsquamous non-small cell lung cancer (NSCLC), according to … has progressed despite chemoimmunotherapy.
Lung cancer remains the leading cause … release. Standard-of-care docetaxel in a similar patients … head and neck, and lung cancers.
The new NSCLC findings …
-
The Efficacy and Safety of Anlotinib Treatment for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who Achieved Stable Disease (SD) After Two Cycles of First-Line Chemotherapy Combined with Immunotherapy: A Retrospective Cohort Study
14 Nov 2025 21:29 GMT
… A. Evolving trends in lung cancer: epidemiology, diagnosis, … docetaxel or pemetrexed shows promising activities against non-small cell lung cancer … non-small cell lung cancer. Lung Cancer. 2018;122:32 … non-small cell lung cancer (NSCLC). Lung Cancer. 2024;187: …
-
<![CDATA[Amtagvi Prompts Responses in Non–Small Cell Lung Cancer]]>
06 Nov 2025 20:31 GMT
… non-squamous non-small cell lung cancer without actionable genetic mutations, new … non-squamous non-small cell lung cancer and a potential launch in … durability — with standard-of-care docetaxel monotherapy showing an ORR of …
-
Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746
06 Nov 2025 14:10 GMT
… docetaxel in patients with non-small-cell lung cancer … mutant non-small cell lung cancer. Lung Cancer. 2014;86(2 … EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer. 2017 … advanced non-small-cell lung cancer. Lung Cancer. 2022;166:9– …
-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
03 Nov 2025 12:00 GMT
… durability. Standard-of-care docetaxel monotherapy in patients with … About Non-Small Cell Lung Cancer
Lung cancer is the most commonly … ,4 Approximately 85% of lung cancer cases are NSCLC, with … our non-small cell lung cancer clinical trials) and our …
-
The Value of Dynamic of Alkaline Phosphatase and Neutrophil-to-Lymphocyte Ratio in Predicting the Efficacy of Neoadjuvant Immunochemotherapy in Patients with Non-Small Cell Lung Cancer
25 Oct 2025 08:42 GMT
… docetaxel in patients with previously treated non-small-cell lung cancer … cell lung cancer patients treated with nivolumab. Lung Cancer. … -Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy … Assessment of Lung Cancer Resection Specimens …
About
© 1995-2025